Theranexus Société Anonyme (ALTHX.PA)

EUR 0.39

(-0.25%)

Total Assets Summary of Theranexus Société Anonyme

  • Theranexus Société Anonyme's latest annual total assets in 2023 was 7.23 Million EUR , down -39.95% from previous year.
  • Theranexus Société Anonyme's latest quarterly total assets in 2024 Q2 was 4.26 Million EUR , down 0.0% from previous quarter.
  • Theranexus Société Anonyme reported annual total assets of 12.05 Million EUR in 2022, down -28.63% from previous year.
  • Theranexus Société Anonyme reported annual total assets of 16.88 Million EUR in 2021, down -3.32% from previous year.
  • Theranexus Société Anonyme reported quarterly total assets of 7.97 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Theranexus Société Anonyme reported quarterly total assets of 7.23 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Theranexus Société Anonyme (2023 - 2015)

Created with Highcharts 11.1.0YearsTotal Assets2015201620172018201920202021202220230 EUR5000000 EUR10000000 EUR15000000 EUR20000000 EUR25000000 EUR

Historical Annual Total Assets of Theranexus Société Anonyme (2023 - 2015)

Year Total Assets Total Assets Growth
2023 7.23 Million EUR -39.95%
2022 12.05 Million EUR -28.63%
2021 16.88 Million EUR -3.32%
2020 17.47 Million EUR 13.67%
2019 15.36 Million EUR -18.46%
2018 18.84 Million EUR -7.49%
2017 20.37 Million EUR 607.31%
2016 2.88 Million EUR 5.67%
2015 2.72 Million EUR 0.0%

Peer Total Assets Comparison of Theranexus Société Anonyme

Name Total Assets Total Assets Difference
ABIONYX Pharma SA 14.71 Million EUR 50.797%
ABIVAX Société Anonyme 327.06 Million EUR 97.787%
Adocia SA 24.95 Million EUR 70.998%
Aelis Farma SA 26.28 Million EUR 72.46%
Biophytis S.A. 11.93 Million EUR 39.362%
Advicenne S.A. 12.4 Million EUR 41.664%
genOway Société anonyme 31.84 Million EUR 77.27%
IntegraGen SA 8 Million EUR 9.532%
Medesis Pharma S.A. 1.92 Million EUR -275.726%
Neovacs S.A. 47.53 Million EUR 84.773%
NFL Biosciences SA 3.97 Million EUR -82.282%
Plant Advanced Technologies SA 14.91 Million EUR 51.467%
Quantum Genomics Société Anonyme 3.74 Million EUR -93.173%
Sensorion SA 46.49 Million EUR 84.433%
TME Pharma N.V. 2.49 Million EUR -190.555%
Valbiotis SA 33.24 Million EUR 78.231%
TheraVet SA 7.53 Million EUR 3.935%
Valerio Therapeutics Société anonyme 35.27 Million EUR 79.481%
DBV Technologies S.A. 165.65 Million USD 95.631%
Genfit S.A. 173.87 Million EUR 95.837%
GeNeuro SA 6.31 Million EUR -14.65%
Innate Pharma S.A. 184.19 Million EUR 96.071%
Inventiva S.A. 69.13 Million EUR 89.532%
MaaT Pharma SA 42.93 Million EUR 83.141%
MedinCell S.A. 36.94 Million EUR 80.411%
Nanobiotix S.A. 93.89 Million EUR 92.292%
OSE Immunotherapeutics SA 81.9 Million EUR 91.163%
Poxel S.A. 4.82 Million EUR -50.067%
GenSight Biologics S.A. 9.08 Million EUR 20.351%
Transgene SA 45.21 Million EUR 83.993%
Valneva SE 469.39 Million EUR 98.458%